- CUE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
10-K/A Filing
Cue Biopharma (CUE) 10-K/A2019 FY Annual report (amended)
Filed: 12 Mar 20, 5:16pm
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement (No.333-229140) on FormS-3 and Registration Statements (Nos.333-224018 and333-230282) on FormS-8 of Cue Biopharma, Inc. of our report dated March 11, 2020, relating to the consolidated financial statements of Cue Biopharma, Inc. and Subsidiary, appearing in this Annual Report on Form10-K of Cue Biopharma, Inc. for the year ended December 31, 2019.
/s/ RSM US LLP
Boston, Massachusetts
March 12, 2020
We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.